Keyphrases
Luminal Breast Cancer
90%
Pancreatic Cancer
75%
P27Kip1
73%
Tumor
63%
Epithelial Ovarian Cancer
54%
Radiotherapy
52%
Tumorigenesis
45%
Breast Cancer Cells
37%
Breast Cancer
37%
Ovarian Cancer Patients
36%
Bevacizumab
36%
Pancreatic Ductal Adenocarcinoma
35%
Radiotherapy-induced
34%
CDKN1B
33%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
33%
Copy number Variation
30%
Tissue Damage
30%
Lymph Node Metastasis
30%
Angiogenesis-related Genes
30%
Prognostic Biomarker
30%
Acinar-to-ductal Metaplasia
30%
Platinum Resistance
30%
Epithelial Cells
30%
MEK1
30%
Translational Studies
30%
Colorectal Cancer
30%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
30%
Radioresistance
30%
MicroRNA-223
30%
Cyclin-dependent Kinase 4 (CDK4)
30%
MiR-9
30%
Metastatic Dissemination
30%
Pathologist
30%
Trametinib
30%
Clonal Dominance
30%
Evolutionary Landscape
30%
Mango
30%
EGFR Inhibition
30%
Risk Assessment
30%
Pancreatic Tumorigenesis
30%
Inflammation
30%
Genomic Instability
30%
Non-canonical
30%
MiR-223
30%
Solid Tumors
30%
Tumor Aggressiveness
30%
Inflammatory Events
30%
Epigenome
30%
HEC-RAS
30%
Early Events
30%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
90%
CDKN1B
67%
Cancer Cell
60%
KRAS
60%
Stathmin
60%
Cyclin-Dependent Kinase
53%
Epidermal Growth Factor Receptor
50%
MicroRNA
50%
Dynamics
48%
Tumor Progression
47%
Interferon
40%
Copy-Number Variation
37%
Fibroblast
30%
Cetuximab
30%
Actin
30%
Chromosome Instability
30%
Endogenous Retrovirus
30%
Epidermal Growth Factor
30%
Bevacizumab
30%
Radiosensitivity
30%
Downregulation
30%
Mouse Model
30%
Angiogenesis
30%
Genome Instability
30%
Trametinib
30%
E2F1
30%
Cytoskeleton
30%
DNA Damage
20%
Metaplasia
20%
Genomics
20%
Epigenetics
20%
Transgenic Mouse
18%
Mouse Mammary Tumor Virus
18%
Cell Proliferation
17%
C-Terminus
16%
Repressor
15%
Organ Growth
15%
Cell Growth
15%
Oncogene
15%
Transcriptomics
15%
Transcription
15%
Knockout Mouse
13%
Genome Editing
10%
Reprogramming
10%
Adaptive Response
10%
Double-Stranded RNA
10%
Proliferating Cell Nuclear Antigen
10%
IRF1
10%
Tumor Suppressor Protein
10%
DNA Repair
10%
Medicine and Dentistry
Neoplasm
100%
Pancreas Cancer
75%
Breast Cancer
60%
Recurrent Disease
50%
Cancer Cell
35%
Neck
33%
Carcinoma
33%
Germ Layer
30%
microRNA 223
30%
CDKN1B
30%
Epidermal Growth Factor
30%
Evolution
30%
Head and Neck Squamous Cell Carcinoma
30%
Pancreas Adenocarcinoma
30%
Mediator
30%
Endogenous Retrovirus
30%
Radiation Therapy
30%
Copy Number Variation
30%
Trametinib
30%
Solid Malignant Neoplasm
30%
Krukenberg Tumor
30%
Tissue Inhibitor of Metalloproteinase 1
30%
microRNA
25%
Tumor Progression
25%
Epidermal Growth Factor Receptor
20%
Interferon
20%
Drug Resistance
19%
Malignant Neoplasm
18%
Rare Tumor
15%
Chromatin Remodeling
15%
Glioblastoma
15%
Cancer
15%
Carcinogenesis
15%
Breast Tissue
15%
Cancer Pathobiology
15%
Finger Dermatoglyphics
15%
Medicine
15%
Ovarian Cancer
15%
Biological Marker
10%
Cancer Growth
10%
Immunoglobulin
10%
Therapy Effect
10%
Transcription Factor
10%
Retroposon
10%
Oncology
10%
Phosphotransferase Inhibitor
10%
Combination Therapy
10%
Double Stranded RNA
10%
Interferon Regulatory Factor 1
10%
Tumor Cell
9%
